December 7, 2025Drug and Alcohol ReviewOpen Access

The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction—A Narrative Review

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Narrative review highlights emerging novel benzodiazepines in Australia, suggesting urgent clinical management and harm reduction interventions.

NBZs show increasing detection in emergency department and forensic data, revealing significant public health risks.
Between 2020 and 2025, drugs like clonazolam and bromazolam were frequently identified in Australian toxicological data.
Analysis conducted via a narrative review of relevant databases and drug alerts to summarize current literature on harm reduction.
Urgent action is required to address clinical management and dependence challenges posed by novel benzodiazepines.

Freestone et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 7, 2025Drug and Alcohol ReviewOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Narrative review highlights emerging novel benzodiazepines in Australia, suggesting urgent clinical management and harm reduction interventions.

NBZs show increasing detection in emergency department and forensic data, revealing significant public health risks.
Between 2020 and 2025, drugs like clonazolam and bromazolam were frequently identified in Australian toxicological data.
Analysis conducted via a narrative review of relevant databases and drug alerts to summarize current literature on harm reduction.
Urgent action is required to address clinical management and dependence challenges posed by novel benzodiazepines.

Freestone et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark